You are viewing: India Synthetic Biology Market analysis
Part of: Synthetic Biology Market (Global)

The India Synthetic Biology Market was valued at $50.8 Million in 2024 and projected to reach to $140.8 Million by 2029, representing a compound annual growth rate of 22.6%. India's synthetic biology market is poised for exceptional growth over the next five years, driven by strategic government policies, substantial biotech infrastructure investments, and a growing pool of skilled researchers.

India Synthetic Biology Market (2024-2029) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

India Synthetic Biology Market Trends and Insights

  • India is emerging as a key hub for synthetic biology innovation in the Asia Pacific region, driven by increasing investments in biotechnology infrastructure, growing pharmaceutical and agricultural applications, and rising government support for life sciences research.
  • The market in India is benefiting from a large pool of skilled researchers, cost-competitive manufacturing capabilities, and expanding collaborations between academic institutions and industry players. The synthetic biology sector in India is witnessing accelerated adoption across multiple end-use industries, including pharmaceuticals, diagnostics, agriculture, and industrial biotechnology.
  • India's favorable regulatory environment and initiatives like the National Biotechnology Development Strategy are catalyzing market expansion.
  • By 2029, India is expected to consolidate its position as a significant contributor to the global synthetic biology ecosystem, with the market growing at a compound annual growth rate of 22.6%, substantially outpacing global trends..

Key Market Statistics

  • CAGR (2024-2029) 22.6% CAGR
  • Market Size, 2024 ~USD 50.8 Million
  • Forecast, 2029 ~USD 140.8 Million
  • Country India

India Synthetic Biology Market Overview

Rapid Market Expansion :

India's synthetic biology market is projected to grow from $50.8 million in 2024 to $140.8 million by 2029, representing a robust CAGR of 22.6%, outpacing the global growth rate of 20.6%.

Asia Pacific Hub Status :

India is establishing itself as a critical innovation and manufacturing hub for synthetic biology in the Asia Pacific region, attracting significant biotech investments and research collaborations.

Government Support & Infrastructure :

Rising government initiatives and increased investments in biotechnology infrastructure are creating a favorable ecosystem for synthetic biology development, research, and commercialization across India.

Diverse Application Growth :

Expanding pharmaceutical and agricultural applications of synthetic biology are driving market demand, with emerging opportunities in diagnostics, therapeutics, and sustainable crop development.

India Synthetic Biology Market Dynamics

  • The country's competitive manufacturing costs and large pharmaceutical sector create significant opportunities for synthetic biology applications in drug development and personalized medicine.
  • Agricultural biotechnology represents another high-growth segment, addressing food security and sustainable farming challenges across India's diverse regions. The convergence of increasing venture capital funding, academic research excellence, and industry partnerships is accelerating innovation cycles in India's synthetic biology ecosystem.
  • With supportive regulatory frameworks and rising collaborations between Indian biotech firms and global leaders, the market is expected to attract substantial foreign direct investment.
  • This momentum positions India as a preferred destination for synthetic biology R&D and production, contributing meaningfully to the region's biotechnology advancement..

Market Ecosystem

logo-mobile

Related Ecosystem

Advanced Genetic Sequencing

Top Technologies
  • Polymerase Chain Reaction (PCR)
  • Reagents
  • Assay Kits
  • Bioinformatics
  • Flow Cytometry
Top Companies
  • Thermo Fisher Scientific Inc.
  • Illumina, Inc.
  • Agilent Technologies, Inc.
  • Qiagen N.V.
  • Danaher Corporation

    Biotechnology

    Top Technologies
    • Reagents
    • Polymerase Chain Reaction (PCR)
    • Stem Cells
    • Assay Kits
    • Flow Cytometers
    Top Companies
    • Thermo Fisher Scientific Inc.
    • Merck KGaA
    • Danaher Corporation
    • Agilent Technologies, Inc.
    • Bio-Rad Laboratories, Inc.

      Key Takeaways

      • India's synthetic biology market is valued at $50.8 million in 2024 and is forecast to reach $140.8 million by 2029, representing a 22.6% CAGR.
      • India is leveraging its cost-competitive manufacturing base and skilled workforce to establish itself as a regional leader in synthetic biology innovation.
      • Government support through biotechnology initiatives and favorable regulatory policies is accelerating market growth across pharmaceuticals, diagnostics, and agriculture sectors in India.
      • India's synthetic biology market growth rate of 22.6% significantly exceeds the global CAGR of 20.6%, positioning the country as a high-growth market in the Asia Pacific region.

      Synthetic Biology Market Report Scope

      Report Metric Details
      Base Year 2024
      Fastest Growing Segment GENOME ENGINEERING (Technology)
      Forecast Period 2024-2029
      Growth Rate CAGR of 20.6% from 2024 to 2029
      Largest Segment MEDICAL APPLICATIONS (Application)
      Market Size Base Year (Billions) ~USD 12.36 (2024)
      Revenue Forecast (Billions) ~USD 31.52 (2029)
      Segments Covered Tool, Technology, Application, Type, Industry

      India Synthetic Biology Market Report Segmentation

      5 segment dimensions are covered across the global market.

      By Tool

      • Chassis Organisms
      • Cloning Technology Kits
      • Enzymes
      • Oligonucleotides & Synthetic Dna
      • Synthetic Cells
      • Xeno Nucleic Acids

      By Technology

      • Bioinformatics
      • Cloning
      • Gene Synthesis
      • Genome Engineering
      • Measurement & Modeling
      • Microfluidics
      • Nanotechnology
      • Sequencing
      • Site-Directed Mutagenesis

      By Application

      • Environmental Applications
      • Food, Animal Health, And Agricultural Applications
      • Industrial Applications
      • Medical Applications

      By Type

      • Artificial Tissue & Tissue Regeneration
      • Biofuel & Renewable Energy
      • Biofuels & Renewable Energy
      • Biomaterials & Green Chemicals
      • Bioremediation
      • Biosensing
      • Biosynthesis
      • Cancer Detection & Diagnostics
      • Drug Discovery & Therapeutics
      • Flavors & Fragrances
      • Industrial Enzymes
      • Other Artificial Tissue & Tissue Regeneration Applications
      • Other Consumer Care Products
      • Other Drug Discovery & Therapeutic Applications
      • Other Food, Animal Health, And Agricultural Applications
      • Pharmaceuticals
      • Skincare & Cosmetics
      • Stem Cell Regulation

      By Industry

      • Consumer Care Industry
      • Other Industries
      • Paper Industry
      • Textile Industry

      INDIA: SYNTHETIC BIOLOGY MARKET FOR INDUSTRIAL ENZYMES, BY INDUSTRY, 2022–2029

      Segment20222023202420252026202720282029CAGR (%)
      CONSUMER CARE INDUSTRY2.52.62.72.93.54.25.47.222
      OTHER INDUSTRIES2.92.933.23.64.25.26.616.9
      PAPER INDUSTRY2.9333.23.64.35.36.817.9
      TEXTILE INDUSTRY6.46.76.87.48.610.312.916.919.8
      TOTAL14.615.215.516.819.22328.837.419.3

      Target Audience

      • Biotech & Pharmaceutical Companies : Require India-specific market data to evaluate expansion opportunities, assess competitive positioning, and develop localized strategies for synthetic biology product launches and R&D investments.
      • Venture Capital & Private Equity Firms : Need detailed market sizing and growth projections for India to identify promising investment targets, assess portfolio company potential, and allocate capital effectively in the region's biotech sector.
      • Government & Policy Makers : Utilize market intelligence to inform biotechnology policy development, infrastructure investments, and regulatory frameworks that support India's synthetic biology ecosystem growth and innovation.
      • Academic & Research Institutions : Require market insights to align research initiatives with commercial opportunities, secure funding, and establish industry partnerships that translate synthetic biology innovations into practical applications.
      • Agricultural & Food Security Organizations : Need India-focused synthetic biology market data to understand opportunities in crop development, sustainable farming solutions, and food security applications within the country's agricultural sector.

      Reasons to Buy this Report

      • Market Size & Growth Validation : Obtain precise market valuation data for India ($50.8M in 2024) with verified 5-year forecasts and CAGR metrics to support investment decisions and business planning in the region.
      • Competitive Positioning Intelligence : Understand India's market dynamics relative to global trends (22.6% vs 20.6% CAGR) to identify competitive advantages and strategic opportunities for market entry or expansion.
      • Sector-Specific Application Insights : Access detailed analysis of pharmaceutical and agricultural synthetic biology applications in India, enabling targeted product development and go-to-market strategies for these high-growth segments.
      • Investment & Partnership Opportunities : Leverage comprehensive market intelligence on India's biotech infrastructure, government support mechanisms, and funding landscape to identify strategic partnership and investment opportunities.
      • Regulatory & Ecosystem Landscape : Gain insights into India's supportive regulatory environment, research capabilities, and manufacturing advantages to optimize operational strategies and resource allocation in the region.

      Frequently asked questions

      What is the current size of India's synthetic biology market?

      India's synthetic biology market was valued at $50.8 million in 2024 and is expected to grow to $140.8 million by 2029.

      What is the projected growth rate for synthetic biology in India?

      India's synthetic biology market is projected to grow at a compound annual growth rate (CAGR) of 22.6% from 2024 to 2029.

      Which industries are driving synthetic biology adoption in India?

      Key industries driving synthetic biology adoption in India include pharmaceuticals, diagnostics, agriculture, and industrial biotechnology.

      Why is India becoming a hub for synthetic biology?

      India is becoming a synthetic biology hub due to its cost-competitive manufacturing, skilled research workforce, government support through biotechnology initiatives, and favorable regulatory environment.

      How does India's synthetic biology market growth compare to global trends?

      India's synthetic biology market is growing at 22.6% CAGR, which exceeds the global CAGR of 20.6%, making it one of the fastest-growing markets in the Asia Pacific region.

      RESEARCH METHODOLOGY

      The research study involved the wide use of secondary sources, directories, and databases to identify and collect valuable information for the analysis of the global synthetic biology market. Extensive interviews were conducted with various primary participants, including key industry members, subject-matter experts (SMEs), C-level managers of leading market players, and industry consultants, to obtain and verify qualitative and quantitative information and evaluate the growth scenarios of the market. The global market size is estimated through secondary research (top-down and bottom-up) followed by data triangulation with inputs from industry experts to arrive at the final market size.

      Secondary Research

      Secondary research was used mainly to identify and collect information for the technical, market-oriented, and commercial study of the synthetic biology market. The secondary sources used for this study include World Health Organization (WHO), Organisation for Economic Co-operation and Development (OECD), Lens.org, National Center for Biotechnology Information (NCBI), Imperial College Centre for Synthetic Biology, Institute of Systems & Synthetic Biology (iSSB), University of California San Francisco (UCSF), Center for Systems and Synthetic Biology, Synthetic Biology Leadership Council (SBLC), Engineering Biology Advisory Committee, Synthetic Biology Engineering Research Center (SynBERC), Biotechnology and Biological Sciences Research Council (BBSRC), Helmholtz Association of German Research Centres, Asian Synthetic Biology Association, World Bank, Academic Journals and Company Websites, corporate & regulatory filings, such as annual reports, SEC filings, investor presentations, and financial statements; business magazines & research journals; press releases; and trade, business, and professional associations among others. These secondary sources were also used to obtain major information about key market players, and market segmentation corresponding to industry trends, regional/country-level markets, market developments, and technology prospects. Secondary data was collected and analysed to arrive at the market size of the global synthetic biology market, which was further validated through primary research.

      Primary Research

      Extensive primary research was conducted after acquiring basic knowledge about the global synthetic biology market scenario through secondary research. Several primary interviews were conducted with market experts from the demand side, such as pharmaceutical & biopharmaceutical industries from the supply side, such as C-level and D-level executives, product managers, marketing & sales managers of key manufacturers, distributors, and channel partners. The primary interviews were conducted across six major regions, including the North America, Europe, Asia Pacific, Latin America, Middle East and Africa. Approximately 70% and 30% of the primary interviews were conducted with supply-side and demand-side participants, respectively. This primary data was collected through questionnaires, e-mails, online surveys, personal interviews, and telephonic interviews.

      The following is a breakdown of the primary respondents:

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      Both top-down and bottom-up approaches were used to estimate and validate the total size of the synthetic biology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

      Data Triangulation

      After arriving at the market size from the market size estimation process explained above, the total market was divided into several segments and subsegments. To complete the overall market engineering process and arrive at the exact statistics for all segments and subsegments, data triangulation and market breakdown procedures were employed, wherever applicable. The data was triangulated by studying various factors and trends from both the demand and supply sides.

      Market Definition

      Synthetic biology involves the redesign of natural biological systems by engineering and designing new biological parts and functions, namely synthetic biological pathways and organisms, which are used to construct end products. It is an innovative research area broadly comprising of multiple disciplines, such as biotechnology, molecular biology, genetic engineering, and biophysics, among others.

      Stakeholders

      • Companies Providing Synthetic Biology Tools, Technologies, and Related Products & Services
      • Research Institutes and Academic Centers
      • Suppliers and Distributors of Synthetic Biology Tools & Technologies
      • Pharmaceutical and Biotechnology Companies
      • Agricultural and Veterinary companies
      • Business Research and Consulting Service Providers
      • Venture Capitalists
      • Contract Research Organizations and Contract Development Manufacturing Organizations
      • Market research and consulting firms

      Report Objectives

      • To define, describe, and forecast the synthetic biology market by value by tool, technology, application, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall Synthetic biology market
      • To analyze the opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to six regions: North America, Europe, the Asia Pacific, Latin America, Middle East and Africa
      • To profile the key players and analyze their market shares and core competencies2
      • To track and analyze competitive developments, such as product launches, partnerships, agreements, collaborations, and expansions
      • To benchmark players within the market using the proprietary “Company Evaluation Matrix” framework, which analyzes market players on various parameters within the broad categories of business and product excellence strategy

      Get the Full Synthetic Biology Market Report

      Full forecast, segment splits, and company analysis for all Synthetic Biology Market.

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      DMCA.com Protection Status